Stonepine Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $958K | Buy |
|
|||||
|
2025
Q1 | $561K | Sell |
|
|||||
|
2024
Q4 | $618K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.32M | Sell |
|
|||||
|
2023
Q4 | $14M | Buy |
|
|||||
|
2023
Q3 | $11M | Buy |
|
|||||
|
2023
Q2 | $14.4M | Sell |
|
|||||
|
2023
Q1 | $14.1M | Sell |
|
|||||
|
2022
Q4 | $14.9M | Sell |
|
|||||
|
2022
Q3 | $20.2M | Buy |
|
|||||
|
2022
Q2 | $17.9M | Buy |
|
|||||
|
2022
Q1 | $20.3M | Buy |
|
|||||
|
2021
Q4 | $16.6M | Buy |
|